Arena Pharmaceuticals, Inc. Made Big Gain
Mon, Dec 13, 2021 at 05:30 PM
Arena Pharmaceuticals, Inc. (ARNA:NASDAQ) soared at $90.08, a gain of 80.4%. The stock appeared on our News Catalysts scanner on Mon, Dec 13, 2021 at 03:37 PM in the 'ACQUISITION' category. From Fri, Nov 26, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Arena Pharmaceuticals, Inc. (ARNA:NASDAQ)
Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.
Top 10 Gainers:
- SeaChange International, Inc. (SEAC:NASDAQ), 128.81%
- Arena Pharmaceuticals, Inc. (ARNA:NASDAQ), 80.38%
- FHTX (FHTX:NASDAQ), 54.96%
- BELLUS Health Inc. (BLU:NASDAQ), 48.21%
- PTPI (PTPI:NASDAQ), 47.41%
- Energy Focus, Inc. (EFOI:NASDAQ), 36.23%
- East Stone Acquisition Corporation (ESSC:NASDAQ), 31.43%
- Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 30.22%
- Puxin Limited (NEW:NYSE), 27.13%
- BFRI (BFRI:NASDAQ), 27%